Therefore, identification of such endogenous INSR regulators will aid efforts to understand the cellular regulation of insulin signalling and may reveal new therapeutic targets for the treatment of T2D and other pathologies related to aberrant insulin signalling. The gene discussed is INS; the disease is type 2 diabetes mellitus.